Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Bristol-Myers Squibb patents RORgamma modulators

April 13, 2015

Calitor Sciences discloses new PI3K inhibitors

April 13, 2015

Pharmakea divulges autotaxin inhibitors

April 13, 2015

Max Planck Society presents synthetic pneumococcal vaccines

April 13, 2015

Calitor Sciences and Sunshine Lake Pharma develop PI3Kdelta inhibitors

April 10, 2015

Tetra Discovery Partners discloses PDE4 inhibitors

April 10, 2015

Vernalis reports development of PDK inhibitors

April 10, 2015

Merck & Co. patents HIV integrase inhibitors

April 10, 2015

Bristol-Myers Squibb describes mGlu2 receptor PAMs

April 9, 2015

Calitor Sciences develops PI3Kdelta inhibitors

April 9, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...